FdaApplication
ANDA 209728
Identifiers
- fda_app_no: ANDA209728
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2025-01-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REGORAFENIB | REGORAFENIB | 40MG | TABLET;ORAL |
1 product